scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0169-328X(98)00212-5 |
P698 | PubMed publication ID | 9795212 |
P2093 | author name string | Roy S | |
Loh HH | |||
Barke RA | |||
P2860 | cites work | Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia | Q28585437 |
Effects of opioids on the immune system | Q34409796 | ||
Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice | Q36377123 | ||
Molecular characterization of opioid receptors | Q37879023 | ||
Opioid peptides and opioid receptors in cells of the immune system | Q39222376 | ||
The Major Medical Complications of Heroin Addiction | Q40049605 | ||
Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene | Q41157124 | ||
Differential effects of opioids on the proliferation of a macrophage cell line, Bac 1.2F5. | Q41203621 | ||
Effect of chronic opioid treatment on phagocytosis in Tetrahymena | Q43558348 | ||
Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages | Q44344063 | ||
mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality | Q44348420 | ||
mu-Opioid receptor-knockout mice: the role of mu-opioid receptor in gastrointestinal transit | Q44348820 | ||
Morphine modulates NF kappa B activation in macrophages | Q45100921 | ||
Morphine Tolerance, Physical Dependence, and Synthesis of Brain 5-Hydroxytryptamine | Q49118851 | ||
Effect of high doses of morphine on Con-A induced lymphokine production in vitro. | Q50800123 | ||
In vitro evaluation of fentanyl and meperidine for immunomodulatory activity | Q51605444 | ||
Morphine-induced immunomodulation is not related to serum morphine concentrations | Q68095897 | ||
Inhibition by opioids of phagocytosis in peritoneal macrophages | Q68303178 | ||
Morphine inhibits transcriptional activation of IL-2 in mouse thymocytes | Q73592968 | ||
P433 | issue | 1-2 | |
P921 | main subject | morphine | Q81225 |
opioid | Q427523 | ||
knockout mouse | Q1364740 | ||
P304 | page(s) | 190-194 | |
P577 | publication date | 1998-10-01 | |
P1433 | published in | Molecular Brain Research | Q6895939 |
P1476 | title | MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions | |
P478 | volume | 61 |
Q44373646 | Augmented production of proinflammatory cytokines and accelerated allotransplantation reactions in heroin-treated mice. |
Q37956171 | Behavioral and molecular evidence for a feedback interaction between morphine and HIV-1 viral proteins |
Q35233407 | Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone |
Q45054320 | Connexin-purinergic signaling in enteric glia mediates the prolonged effect of morphine on constipation |
Q43120295 | Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands |
Q44887369 | Correlation between the administration of morphine or oxycodone and the development of infections in patients with cancer pain |
Q30426775 | Cross-Talk between Metabolism and Reproduction: The Role of POMC and SF1 Neurons |
Q36595442 | Differential effects of gram-positive and gram-negative bacterial products on morphine induced inhibition of phagocytosis. |
Q44339364 | Differential promoter usage of mouse mu-opioid receptor gene during development |
Q40337189 | Do fentanyl and morphine influence body temperature after severe burn injury? |
Q90087607 | Effect of morphine and a low dose of ketamine on the T cells of patients with refractory cancer pain in vitro |
Q37587850 | Endomorphin 1 and endomorphin 2 suppress in vitro antibody formation at ultra-low concentrations: anti-peptide antibodies but not opioid antagonists block the activity. |
Q44340176 | Enhanced humoral response in kappa-opioid receptor knockout mice |
Q34641459 | Exploring the opioid system by gene knockout |
Q49052189 | Generation of dynorphin knockout mice |
Q34158930 | Glycogen synthase kinase-3 and p38 MAPK are required for opioid-induced microglia apoptosis |
Q43981293 | Immune modulation in gastrointestinal disorders: new opportunities for therapeutic peptides? |
Q36191017 | Immunomodulatory effect of morphine: therapeutic implications |
Q90138345 | Implications of Chronic Opioid Therapy on Perioperative Complications and Long-Term Surgical Recovery |
Q44233550 | Increased splenocyte proliferative response and cytokine production in beta-endorphin-deficient mice |
Q44341415 | Inducible expression of functional mu opioid receptors in murine dendritic cells |
Q40561436 | Methadone enhances human influenza A virus replication |
Q34926928 | Microbial Infections, Immunomodulation, and Drugs of Abuse |
Q37015395 | Modulation of immune function by morphine: implications for susceptibility to infection |
Q35952061 | Morphine decreases bacterial phagocytosis by inhibiting actin polymerization through cAMP-, Rac-1-, and p38 MAPK-dependent mechanisms |
Q34562535 | Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner |
Q43765109 | Morphine inhibits indolactam V-induced U937 cell adhesion and gelatinase secretion |
Q42169348 | Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways |
Q35602449 | Morphine potentiates LPS-induced autophagy initiation but inhibits autophagosomal maturation through distinct TLR4-dependent and independent pathways |
Q47854561 | Morphine-Mediated Brain Region-Specific Astrocytosis Involves the ER Stress-Autophagy Axis |
Q46880712 | Morphine-induced neuroimmunomodulation in murine visceral leishmaniasis: the role(s) of cytokines and nitric oxide |
Q44349917 | Mu and delta receptors mediate morphine effects on phagocytosis by murine peritoneal macrophages |
Q35760524 | Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation. |
Q34169318 | N-naphthoyl-beta-naltrexamine (NNTA), a highly selective and potent activator of μ/kappa-opioid heteromers |
Q73755556 | Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats |
Q36245077 | Nuclear factor kappaB signaling in opioid functions and receptor gene expression |
Q44343466 | Opioid analgesics stop the development of clostridial gas gangrene |
Q36694953 | Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections |
Q35142942 | Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated? |
Q33842214 | Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis |
Q90582469 | Opioids, gliosis and central immunomodulation |
Q34208932 | Potentiating effect of morphine on oral Salmonella enterica serovar Typhimurium infection is μ-opioid receptor-dependent |
Q37241460 | Prenatal opiate exposure attenuates LPS-induced fever in adult rats: role of interleukin-1beta |
Q34257530 | Quantitative aspects of stress-induced immunomodulation |
Q44330314 | Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice |
Q43662399 | Role of hypothalamic-pituitary axis in morphine-induced alteration in thymic cell distribution using mu-opioid receptor knockout mice |
Q37551339 | Role of the mu-opioid receptor in opioid modulation of immune function |
Q34939936 | Specific regions display altered grey matter volume in μ-opioid receptor knockout mice: MRI voxel-based morphometry |
Q34409452 | Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids. |
Q79184885 | Stress and the immune system |
Q39457258 | Study on the activation of the opioid receptors by a set of morphine derivatives in a well-defined assay system |
Q38350256 | The Role of Nuclear Factor κB in Tumor Necrosis Factor-Regulated Transcription of the Human μ-Opioid Receptor Gene |
Q44351000 | The gut-brain interaction in opioid tolerance |
Q47684883 | Transgenerational modification of hippocampus TNF-α and S100B levels in the offspring of rats chronically exposed to morphine during adolescence |
Q36716624 | Tumor necrosis factor-alpha levels in HIV-1 seropositive injecting drug users |
Q35846683 | μ-Opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer |
Search more.